My neurologist has been talking to me about this new treatment in clinical studies right now.
We're talking myelin repair here!!
Here's the link to the Fact Sheet from Biogen Idec
http://www.biogenidec.com/Files/Filer/VPR/press_materials/aan2013_EN/FactSheet-Anti-LINGO-1-FINAL-7Mar13.pdf
Key point...CLINICAL STUDIES
Biogen Idec has completed two placebo-controlled Phase 1 studies with anti-LINGO-1. These
studies included both healthy volunteers and subjects with MS.
Key findings from the Phase I studies:4
- Following a single IV dose in healthy volunteers and two repeated IV doses in MS subjects,
anti-LINGO-1 appeared to be safe and well tolerated.
- Anti-LINGO-1 pharmacokinetics in serum and CSF appeared to be similar between healthy
subjects and MS subjects.
These findings supported advancing anti-LINGO-1 monoclonal antibody into the Phase 2 clinical
study that is underway
Such exciting news...we should know in a year, maybe 2, if this will be successful. I'll keep you posted...
or check out BIIB033 on "clinicaltrials.gov"
No comments:
Post a Comment